Longevity science

The Indian Patent Office ruled that a local generic drug maker can make and sell a knock-off of drug giant Bayer's exclusive Nexavar,  a cancer drug.

 

This is only the second time in history that a nation has issued a compulsory license for cancer medication.

 

Experts believe that this may threaten the big business of global pharmaceutical firms...